Akero Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $172,870,000.
Profit Margin
| 2017 | 0 | -4.56M | |
|---|---|---|---|
| 2018 | 0 | -81.71M | |
| 2019 | 0 | -43.75M | |
| 2020 | 0 | -79.19M | |
| 2021 | 0 | -100.73M | |
| 2022 | 0 | -108.91M | |
| 2023 | 0 | -151.75M |
AKRO Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 29K | 260K | 244K | 213K | 0 | 0 | 0 |
Gross profit | -29K | -260K | -244K | -213K | 0 | 0 | 0 |
Operating exp. | |||||||
Research and development | 141.79M | 85.28M | 81.75M | 64.91M | 37.04M | 11.88M | 3.48M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | -98K |
Total operating expenses | 172.87M | 115.15M | 100.88M | 80.15M | 45.65M | 13.77M | 4.56M |
Operating income | -172.87M | -115.15M | -100.88M | -80.15M | -45.65M | -13.77M | -4.56M |
Other income (expenses), net | 21.11M | 3.12M | 109K | 947K | 1.89M | -67.93M | 0 |
Income before tax | -151.75M | -112.03M | -100.77M | -79.20M | -43.75M | -81.71M | -4.56M |
Income tax expense | 0 | -3.12M | -41K | -17K | 24K | 0 | -4.97M |
Net income | -151.75M | -108.91M | -100.73M | -79.19M | -43.75M | -81.71M | -4.56M |
Earnings per share | |||||||
Basic EPS | -2.89 | -2.79 | -2.89 | -2.52 | -2.9 | -3.85 | -0.16 |
Diluted EPS | -2.89 | -2.79 | -2.89 | -2.52 | -2.9 | -3.85 | -0.16 |
| Data source | Data source | Data source | Data source | Data source |